February 6th news, yesterdayBiodata TechnologyDECLARE COMPLETION OF THE A+ ROUND OF MORE THAN 600 MILLION YUANFinancing.
According to official information, the current round of financing is financed by Sino-Kangu City of Science, Inc. and Star Company capital. Strategic investments in publicly listed companies such as Man-Hing, Visual China, Thors, etc., continue to be added to the original shareholders ' fund for investment in artificially intelligent industries in Beijing。
The core team of student science and technology, from the Institute of Artificial Intelligence of the University of Chinghua, was one of the first global teams to study multimodular algorithms. The company continues to overlap in the areas of Vincent's video, Tusheng's video, and it's being launched Vidu Q1, Q2, Q3。
Among the most recent lists of international authorities, Vidu Q3 ranks first and second in China worldwide, alongside xAI Grok, leading Runway Gen – 4.5, Google Veo 3.1 and OpenAI Sora 2。
In terms of commercialization, biotechnologies have built product matrices such as Vidu Maas, Vidu Saas, Vidu Agent and Vidu APP, covering more than 200 countries and regions around the world。